SPAST and hereditary spastic paraplegia: The pathogenicity of our patient’s variant is supported by its conservation and also the fact that a previous patient with childhood-onset HSP, manifesting at 1 year of age, had a de novo SPAST variant changing an amino acid residue adjacent to that of our patient (p.Met390Val34 vs our patient’s p.Thr389Ile).